Detall de l'activitat



Novembre
25
2021
XV Congrés de la Societat Catalana d’Immunologia
Congrés
Societat Catalana d'Immunologia
25 i 26 de novembre de 2021 | Online | L'Acadèmia a Can Caralleu
25-11-2021 | 15:00 - 20:00 | Online
16:00 - 16:15Welcome to the XVth CONGRESS of the SCI ( Sessió )
Presentador/a: Pablo Engel Rocamora
16:15 - 17:00Opening Lecture: ( Sessió )
Moderador/a: Pablo Engel Rocamora
Ponent: Friedrich Koch-Nolte
17:00 - 17:30Company sponsored session Becton Dickinson ( Sessió )
Flow Cytometric Monitoring of Anti CD 20 Therapies
Ponent: Bruno Brando
17:30 - 18:00Plenary Session - Cord blood as a starting material for advanced therapies ( Sessió )
Moderador/a: Ramón Gimeno
Ponent: Sergi Querol Giner
18:00 - 20:00Oral Communications I Basic Experimental Immunology ( Sessió )
Moderador/a: Jose Aramburu
Moderador/a: Francisco Lozano Soto
OC1 IRF 1 is required for MDA 5 (IFIH 1 induction by IFN a, LPS and poly(I C) in murine macrophages Carlos
Ponent: Carlos Batlle
OC 2 NK cells eliminate Epstein Barr virus bound to B cells through a specific antibody mediated uptake
Ponent: Elisenda Alari
OC 3 Enforced sialyl Lewis X sLeX display in E selectin ligands by exofucosylation is dispensable for CD 19 CAR T cell activity and bone marrow homing.
Ponent: Diego Sánchez
OC 4 HEK 293 F cell line shows different antigen presentation features than HEK 293
Ponent: Alba Pastor
26-11-2021 | 08:00 - 20:00 | Online
09:00 - 09:30Plenary Session - Advanced immunotherapies for the management of complications post hematopoietic stem cell transplant Multiple uses of mesenquimal cells ( Sessió )
Moderador/a: Francesc Rudilla
Ponent: joaquim Vives Armengol
09:30 - 11:30Oral Communications II Autoimmunity and Clinical Immunology ( Sessió )
Moderador/a: Clara Franco Jarava
Moderador/a: Odette Viñas
OC 5 Association of HLA B* 35 and severe hypersensitivity reactions secondary to benznidazole treatment in chronic Chagas disease patients.
Ponent: Pau Bosch
OC 6 Limitations of commercial assays as diagnostic tests of autoimmune encephalitis.
Ponent: Guillermo Muñoz
OC 7 Dacmecitos study Influence of the type of donation on the inflammatory pattern in lung transplantation.
Ponent: Alberto Sandiumenge Camps
OC 8 Anti Th/To auto antibodies in patients with SSc are the commercial assays good enough?
Ponent: Janire Perurena
OC 9 Interaction between humoral and cutaneous immune response to Candida albicans in plaque psoriasis.
Ponent: Lídia Sans de San Nicolás
OC 10 Peripheral Blood Lymphocyte Subsets at diagnosis of Arthritis in the Elderly differences between elderly onset rheumatoid arthritis and polymyalgia rheumatic.
Ponent: Aina Teniente Serra
11:30 - 12:00Plenary Session - Advanced immunotherapies for the management of complications post hematopoietic stem cell transplant Multiple uses of mesenquimal cells ( Sessió )
Moderador/a: Carles Serra
Ponent: James Hutchinson
12:00 - 12:45Company sponsored lunch session I Beckman Coulter ( Sessió )
Ponent: Michael Kapinsky
Unmasked Targets, Retired Pipettes, Uncharged Sorting And Other Beckman Coulter Innovations In Flow Cytometry
12:45 - 13:15Company sponsored lunch session II Miltenyi Biotec ( Sessió )
Ponent: Daniel Schäfer
Identification of CAR target candidates against pancreatic adenocarcinoma using ultra high content imaging
13:15 - 14:15Ordinary General Meeting Societat Catalana d’Immunologia ( Sessió )
14:15 - 16:30Oral Communications III Tumor Immunology Immunotherapy ( Sessió )
Moderador/a: Alena Gros
Moderador/a: Sonia Guedan
OC 11 MYC inhibition by an Omomyc based therapy abrogates tumor progression and induces immune cell recruitment in models of NSCLC.
Ponent: Sílvia Casacuberta
OC 12 ARI 0001 autorització sota exempció Hospitalària com emprar productes d'immunoteràpia autoritzats després d'un assaig clínic exitòs.
Ponent: Manel Juan Otero
OC 13 Optimizing a FAP CAR T cell for clinical trials.
Ponent: Estela Ortega
OC 14 Pre leukemic CD 34 +CD 19 CD 22 early B cell progenitors might underlie phenotypic escape in patients treated with CD 19 directed immunotherapies.
Ponent: Clara Bueno
OC 15 A novel and efficient tandem CD 19 and CD 22 directed CAR for B cell ALL.
Ponent: Talia Velasco
OC 16 DIF peptides, a new approach to cancer immunotherapy Preliminary studies.
Ponent: Marta Corral
OC 17 CD 137 costimulation counteracts TGF B inhibition of NK cell anti tumor function.
Ponent: Aura Muntasell et
15:55 - 16:30Discussion ( Sessió )
16:45 - 19:00Oral Communications IV COVID 19 ( Sessió )
Moderador/a: Jorge Carrillo
Moderador/a: Gemma Moncunill
OC 18 SARS CoV 2 sculpts the immune system to induce sustained virus specific naïve like and memory B cell responses.
Ponent: Giuliana Magri
OC 19 Clinical course impacts early kinetics and long term magnitude and amplitude of SARS CoV 2 neutralizing antibodies beyond one year after infection.
Ponent: Edwar Pradenas
OC 20 Determinants of early antibody responses to COVID 19 mRNA vaccines in exposed and naive healthcare workers.
Ponent: Gemma Moncunill
OC 21 A new flow cytometry cell based assay to efficiently determine RBD specific neutralization of SARS CoV 2 emerging variants.
Ponent: Pablo Hernández
OC 22 Analysis of Clinical and Laboratory Markers Based on the First COVID 19 Wave in Barcelona Limitations of the Current Clinicopathological Tests Guides the Identification of Effective Biomarkers.
Ponent: Ricardo Pujol Borrell
OC 23 High dose intravenous immunoglobulins might modulate inflammation in COVID 19 patients.
Ponent: Erola Ainsua
OC 24 SARS CoV 2 antibody kinetics in healthcare workers in northern metropolitan Barcelona.
Ponent: Marc Boigues Pons
19:00 - 19:30Plenary Session - Regulatory T cells in Autoimmune diseases ( Sessió )
Moderador/a: Eva Martínez Cáceres
Ponent: Piotr Trzonzowski
19:30 - 19:45Prize to the best communication and poster. Closing of the Congress ( Sessió )
Ponent: Eva Martínez Cáceres